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ABSTRACT: Theophylline is known to undergo vapor phase induced hydrate–anhydrate
pseudopolymorphic transformations, which can affect its bioavailability. In this work,
the kinetics of the pseudopolymorphic transitions of theophylline crystals in different
storage conditions is studied using a vibrational spectroscopic technique. While the
hydration is a single-step process with a half-life time of ca. 5 h, the dehydration occurs
through a two-step mechanism. In addition, the phase stability of hydrate–anhydrate
systems in different relative humidity (RH) conditions was probed. The critical RH
for anhydrous teophylline was found to be at ca. 79%, while the critical RH
for dehydration is ca. 30%.  2007 Wiley-Liss, Inc. and the American Pharmacists Association
J Pharm Sci 96:1366–1379, 2007
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INTRODUCTION
Pharmaceutical companies have experienced
market shortages as unpredicted changes in
polymorphic and pseudopolymorphic (solvates
and hydrates) forms of the drugs have been
observed, which ultimately affect the quality
release and stability testing of finishing dosage
forms. A well-known example of this problematic
quality–activity relationship of a final dosage
form is the case of Norvir1 brand of ritonavir
semisolid capsules.1–4 Commercial start-up of the
drug as a semisolid capsule formulation began in
the early 1996, but 2 years later most of the
final product lots started to fail in the dissolution
tests. It was found that during storage, the
drug converted to a new, until then unknown,
thermodynamically more stable but less soluble
polymorph of ritonavir, leading to a loss of
bioactivity.1–4 Another example of loss of activity
has been reported for phenytoin (a drug used to
control epilepsy), due to storage of the capsules in
damp and cool conditions.5 This has generated a
demand to develop fast and flexible methods of
measurement of polymorphic and pseudopoly-
morphic transformations inline during pharma-
ceutical processing and storage procedures.
It has been reported that approximately one-
third of pharmaceutical solids are able to form
hydrate species, depending on the environmental
conditions.6 This solid-state transformation can
have significant effects on a variety of physical and
chemical properties, and eventually modify the
pharmaceutical properties, such as solubility,
dissolution and bioavailability.7,8 Thus, detection
and understanding of the interactions of water and
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drugs is of utmost relevance in order to improve
and control the quality of the final product.
Raman spectroscopy is a structure-rich
probe that provides an excellent method for
probing solid-state hydrogen bonding interactions
between molecules, including polymorphs and
solvates (including hydrates).9–17 Despite
the similar information content of Raman and
infrared absorption (IR) spectroscopies, Raman
presents several advantages over IR. In the
particular context of the present work, the most
relevant advantage is the low Raman activity of
water vibrations, whose strong infrared activity
tends to mask a wide IR spectrum range. Thus,
Raman spectroscopy has been successfully used
for monitoring the hydration and dehydration
processes of different sugars, such as glucose
and cyclodextrins,18–24 and pharmaceutical
drugs.7,25–28
Theophylline [1,3-dimethyl-xanthine, here-
after named by TP (Fig. 1)] is a natural derivative
of xanthine found mainly in tea, which presents
several pharmaceutical and medical applica-
tions,29–31 and is included in the core essential
medicines list of the World Health Organization
(WHO).32 It has been shown that TP easily under-
goes reversible anhydrous$hydrate transforma-
tions, which significantly affect its solubility and,
consequently, its bioavailability.33–35 Thus, an
evaluation of the hydration and dehydration
behavior and kinetics of TP is particularly relevant
in the development of stable formulations of the
drug.
TP has been reported to exist in a pseudopoly-
morphic monohydrated form (hereafter named as
TPh) and a pair of enantiotropic anhydrous
polymorphs, named forms I and II.35–38 Anhy-
drous form II (hereafter named as TPa) is stable at
room temperature, while form I only occurs at very
high temperatures. In addition, an anhydrous
metastable form, which is monotropic in respect
to TPa, has also been characterized.35–38 This
metastable polymorph (hereafter named as TPm)
is known to form during dehydration at low drying
temperatures.
The crystal structures of both TPa and TPh have
been published,39–41 being evident that the
major structural differences between the two
polymorphs occur in the hydrogen-bonding net-
work. These structural differences have a direct
effect on the vibrational spectra (both in the
position and in the relative intensities of the
bands) as was reported previously by some of
us.42 Thus, neglecting the hydration effects on the
vibrational spectra can be misleading in further
vibrational studies on TP, as was observed in a
study by Gunasekaran et al.43 (for details see
Reference42).
As stated previously, theophylline easily under-
goes TPa!TPh and TPh!TPa transformations,
and both processes have been studied for the bulk
powder38,44–56 and for tablets.57–60 The effects of
different excipients on these hydration and de-
hydration processes have also been evaluated by
different authors.28,61–64 Unfortunately, however,
these studies not only use different techniques
(ranging from thermogravimetric methods to
spectroscopic tools), but they also consider very
different experimental conditions (temperature,
humidity, sample handling and preparation),
known to have a great influence on both pseudo-
polymorphic transformations. This fact is prob-
ably the origin of some of the discrepancies found
in the literature. For instance, the results of
Otsuka et al.57,58 suggest that the hydration rate
of TPa tablets decreases with increase of tableting
pressure and of porosity, while contradictory
results were obtained by Suihko et al.38 In
what concerns the dehydration process of TPh,
different kinetic mechanisms have been sug-
gested.44,51–53,55,57,58 Moreover, very different
values were also determined for the activation
energy (Ea) of the process.
44,51–53,55,57,58 In an
attempt to explain these discrepancies, Agbada
and York51 even suggested that both process
mechanism and activation energy are technique-
dependent. Of course, it is more likely that the
Figure 1. Schematic representation of theophylline
and atom numbering used in the text.
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differences are due to the different experimental
conditions used by the authors.
Attending to the factors described above, it is
particularly important to study the two processes
using the same experimental methodology
(milling degree, temperature, humidity, and ana-
lysis technique). In this context, the methodology
used for the preparation of the samples (see
Experimental Section) was found to yield kinetic
parameters that are not influenced by sample
weight, at least in the range considered (119–
60 mg). Moreover, the use of Raman spectroscopy
has the advantage of allowing the simultaneous
determination of the kinetic parameters of the
process and of the structural changes underlying
it.
In the present work, the hydration and the
dehydration kinetics of TP are monitored by
means of FT-Raman spectroscopy. In the hydra-
tion process, the commercial anhydrous form is
exposed to water atmosphere during different
time intervals, while for the dehydration process
samples of the crystallized hydrated form are
stored at different ambient temperatures during
different time periods. In addition, the critical
relative humidity (RH) values for both anhydrous
and hydrate forms are determined.
RESULTS AND DISCUSSION
This section is organized in two main parts.
Firstly, the technique, the selection of the spectral
regions and the selection of the kinetic para-
meters are described. Secondly, the results
regarding the kinetic parameters and the critical
humidity conditions for the hydration and dehy-
dration of TP forms are presented and discussed.
In a typical Raman spectrum, the intensity of
the scattered light is plotted as a function of the
Raman shift (Dn cm1). The observed intensity of a
Raman band (at a particular Raman shift) is
given by
IA ¼ A  CA ð1Þ
where IA is the observed intensity of the band
associated to component A, dA is the Raman
activity (intrinsic intensity) of the corresponding
vibrational mode, andCA is the relative concentra-
tion of component A in the sample (in the scope of
the present work, the relative concentration of a
given polymorphic or pseudopolymorphic form).
In order to use Raman spectroscopy in the
evaluation of kinetic parameters, it is firstly
necessary to identify the distinct bands due to
the different polymorphic or pseudopolymorphic
forms intervening in the reaction pathway, ‘‘reac-
tant’’ and ‘‘product.’’ Among a given pair of bands
ascribed to the ‘‘reactant’’ and ‘‘product,’’ there will
be a time-dependent intensity transfer during the
reaction.
Selection of the Most Useful Spectral Regions
Figure 2 compares the Raman spectra of TPa and
TPh pure forms (bottom and top, respectively) in
Figure 2. FT-Raman spectra of TPa (bottom) and TPh (top) in the 100–1800 cm1 and
2750–3500 cm1 spectral regions. The regions showing the most pronounced differences
between TP forms are marked.
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the 100–1800 cm1 and 2750–3500 cm1 spectral
regions. The horizontal brackets emphasize the
spectral regions that evidence the most prominent
spectral differences. As can be seen, the spectral
differences between the TPa and TPh forms
spread out through almost the entire spectral
range. According to a previous study,65 these are
related to the stretching modes of the oscillators
C(8)-H (3060–3160 cm
1), C–O (1650–1750 cm1),
C(4)–C(5) (1585–1630 cm
1) and CC and CN
(1540–1585 cm1, 1300–1340 cm1, and 1160–
1203 cm1). The remaining regions shown are
mainly ascribed to deformation modes of the
imidazole and pyrimidine rings.
All these spectral regions were evaluated for
their suitability to be used in the relative quanti-
fication of the two forms, TPa and TPh, using
physical mixtures of known TPa/TPh ratio.
Two main criteria were considered. Firstly, the
existence of an isosbestic point is required. It
is generally accepted that the existence of an
isosbestic point is an indication that only two
species exist in the pathway of a reaction, and that
they interconvert directly.66 Secondly, the number
of bands required for the spectral deconvolution
process should be low, as the spectral regions that
can be described using two single bands in
the deconvolution process are less prone to ‘‘over-
parameterization’’ errors.
Figure 3 shows the Raman spectra of TPa and
TPh in the 3060–3160 cm1, 900–940 cm1, and
650–685 cm1 spectral regions. These regions
were found to be the most amenable for the present
study, as they present a clear isosbestic point and
can be described by the presence of two single
bands. Being so, these are the only regions used in
the scope of the present work (hydration of
TPa and dehydration of TPh). However, in
studies involving mixtures of compounds, such as
mixtures of TP and excipients, the use of other
spectral regions may be required, as it naturally
depends on the degree of overlapping between the
TP and excipient bands (see Experimental Section
for more details).
Determination of Kinetic Parameters
Different kinetic models (f(a)¼kt, where a stands
for the fractional of conversion) have been defined
for characterizing the solid–solid reaction
mechanisms, such as the present pseudopoly-
morphic conversions (Tab. 1).67–69 By plotting f(a)
versus time-of-reaction, a linear relation shall be
obtained, with the corresponding slope giving the
reaction rate of the process.
The values of the fractional of conversion can be
determined by using the relative intensity ratio of
the Raman bands ascribed to each form, TPa
and TPh. That is, the values of the fractional
of hydration (ah) and of dehydration (ad) at a
particular time-of-reaction (of time-of-exposure
to RH conditions or of time-of-storage at a given
temperature) can be determined as
hðtÞ ¼ ITPh½ITPh þ ðTPh=TPaÞITPa ð2Þ
and
aðtÞ ¼ ITPa½ITPa þ ðTPa=TPhÞITPh ð3Þ
Figure 3. Comparison of the FT-Raman spectra of TPa (solid line) and TPh (dashed
line) forms in the 650–685 cm1, 900–940 cm1, and 3060–3160 cm1 spectral regions.
The band intensities are scaled in accordance to the intrinsic intensities of the
corresponding vibrational modes. The spectral features marked with an asterisk are
ascribed to the metastable TPm form (see text).
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respectively (I stands for intensity of the bands
ascribed to the TPh and TPa forms at instant t of
reaction, respectively, and d stand for the intrinsic
intensity of the vibrational mode considered). By
definition, ahþ aa¼ 1.
The different kinetic models of Table 1 were
considered in order to identify the mechanism
underlying either the TPa!TPh and the TPh!
TPa conversions.
Hydration Process of TPa
Figure 4 shows the sequential change of the
C8-H stretching mode spectral region (3060–
3160 cm1) as a function of time-of-exposure to
water saturated atmosphere, at 258C. The time-
dependent intensities observed in the 900–
940 cm1 and 650–685 cm1 spectral regions
present a similar behavior (Fig. 5S of the
Supplementary Material).
The first evidences of the pseudopolymorphic
transformation are detectable after more than 1 h
of exposure. On the other hand, after 6 h of
exposure the band ascribed to the TPa form is just
a weak shoulder, which disappears after 8 h of
exposure. Larger times of exposure did not give
rise to any further eye-observable spectral change,
although a good band fitting evidenced the pre-
sence of small amounts of the TPa form (ca. 1%)
until up to ca. 10 h of exposure.
Figure 5 collects the plots of ah (Eq. 2) as a
function of time, for the three spectral regions. The
values obtained from moisture uptake gravimetric
measurements are also shown for comparison. As
can be seen, all the results are in very good
agreement. Both the fractional of total moisture
uptake (xTPh) and fractional of hydration (ah)
follow very similar sigmoidal curves as a function
of time-of-exposure to water saturated atmosphere
(Fig. 5a).
Both quantities xTPh and ah were fitted to the
different kinetic models listed in Table 1, and it
was found that in all cases the hydration of TPa is
better described by the Avrami–Erofeev random
nucleation approach (Fig. 5b and Tab. 2S of the
Supplementary Material). Table 2 shows the
kinetic results obtained for the TPa hydration
process, using moisture uptake and Raman
measurements. Although the obtained R2- and
sb-values for M9 and M10 kinetic models are
somewhat similar, the former was assumed to
yield a better description of the overall results
(three spectroscopic regions and moisture
uptake measurements). Within this assumption,
the hydration of TPa is a one-step random nuclea-
tion process, described by the Avrami–Erofeev
equation of exponent 12, with a rate constant of
ca. 0.003 min1. The gravimetric moisture
uptake results point to a t1/2 of ca. 276 min.
On the other hand, according to the Raman
experiments half-hydration is obtained after
292–299 min. In addition, while the gravimetric
results indicate completeness of TPa hydration
after ca. 1064 min. of exposure, the FT-Raman
Table 1. Solid-State Reaction Rate Equations and Mechanisms67–69
Model Equation, f(a)¼kta Rate-Controlling Mechanism
M1 1=4 Power law
M2 1=3 Power law
M3 1=2 Power law
M4 3=2 Power law
M5 1  One-dimensional phase boundary reaction (zero-order)
M6 1 ð1  Þ1=2 Two-dimensional phase boundary reaction (cylindrical symmetry)
M7 1 ð1  Þ1=3 Three-dimensional phase boundary reaction (spherical symmetry)
M8  lnð1  Þ Random nucleation (Mampel equation)
M9 ðlnð1  ÞÞ1=2 Random nucleation (Avrami–Erofeev equation; n ¼ 1=2)
M10 ðlnð1  ÞÞ1=3 Random nucleation (Avrami–Erofeev equation; n ¼ 1=3)
M11 ðlnð1  ÞÞ1=4 Random nucleation (Avrami–Erofeev equation; n ¼ 1=4)
M12 ðlnð1  ÞÞ2=3 Random nucleation (Avrami–Erofeev equation; n ¼ 2=3)
M13  Zero-order mechanism (Polany–Wigner equation)
M14 2 One-dimensional diffusion
M15 ð1 Þlnð1  Þ þ  Two-dimensional diffusion
M16 ð1 ð1  Þ1=3Þ2 Three-dimensional diffusion (Jander equation)
M17 1 23 ð1 Þ2=3 Three-dimensional diffusion (Ginstling–Brounshtein equation)
aa stands for TPa!TPh or TPh!TPa degree of conversion;k is the rate constant of the conversion reaction; t is time-of-exposure to
water atmosphere.
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measurements yield values in the range of 1088–
1180 min.
As can be seen in the last lines of Table 2,
different kinetic parameters for the TPa hydration
process (namely times required for half-hydration
(t1/2) and complete hydration (th)) have been
reported in the literature.44,45,49 The results
obtained in the present work differ significantly
from all the previously reported values. These
discrepancies can have several explanations. The
most evident is associated with the different
history of the TPa samples used. For instance, in
the present work the commercial TPa samples
were used, while in the remaining works the TPa
samples were obtained by dehydration of TPh,
which can lead to significantly different sample
morphologies (e.g., grain size and crystal defects).
In fact, it has been found that particle dimensions
affect significantly the hydration rate of TPa,51,58
while Ono et al.56 reported that the increase of
dehydration temperature decreases the rate of
moisture uptake.
Figure 4. FT-Raman spectra, in the 3060–3160 cm1
region, of TP as a function of time of exposure to
RH¼ 100%. The time of exposure (in minutes) is shown
in the right-hand side. Equivalent plots for 650–
685 cm1 and 900–940 cm1 spectral regions are
presented in Figure 4S of the Supplementary Material.
Figure 5. Kinetic data for the TPa hydration process
obtained by moisture uptake measurements (black
squares) and spectral band deconvolution of the 3060–
3160 cm1 (white circles), 650–685 cm1 (black circles),
and 900–940 cm1 (white squares) spectral regions:
(a) plot of fractional moisture uptake (xTPh) and ah
(Eq. 2) as a function of time-of exposure to RH¼ 100%.
(b) Fitting of xTPh- and ah-values to the Avrami–Erofeev
random nucleation (n¼ 0.5) equation.
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The two kinetic quantities t1/2 and th (Tab. 2)
indicate the existence of a small time lag, of
ca. 15–20 min, between the moisture uptake and
the observation of spectral changes due to hydra-
tion. This time lag is easily explained by the two
phenomena involved in the hydration process of
TPa: firstly, the water molecules adsorb to the
surface of the sample, then they diffuse between
TP molecules, leading to the formation of water
channels (thus, initiating the real TPa!TPh
conversion). The gravimetric measurements do
not distinguish between ‘‘structural’’ and ‘‘surface
adsorbed’’ water molecules, while the selected
regions of the Raman spectra are only sensitive
to the structural changes underlying the
TPa!TPh transformation.
Critical RH for TPa Hydration
Pharmaceutical processing may involve contact
with water in different stages of final product
preparation. On the other hand, drug substances
and final drug products are currently submitted
to different temperature and RH conditions
due, for instance, to various climatic conditions.
This can give rise to unexpected hydration
aging phenomena that affect the dissolution
profiles.31,61 Thus, knowledge of the critical RH
of a particular drug is essential to obtain a stable
final dosage. In the case of TPa, the value of the
critical RH is controversial and values ranging
from 25% to 82% (for temperatures around 258C)
have been reported.44,47,70
Figure 6a shows the Raman spectra, in the
region of 3060–3160 cm1, obtained for samples of
TPa (commercial powder) stored at different RH
values for 1 week at 228C, and illustrates the
general behavior observed in all the studied
regions. The corresponding plot of ah ratio versus
RH is shown in Figure 6b. Spectral evidences of the
presence of the TPh form only occur for RH> 79%,
while evidences of the presence of the TPa form
completely vanish for RH> 86%. The ah ratio is
0.23 and 0.86 for the samples exposed to RH¼ 81%
and RH¼ 84%, respectively.
These results indicate that TPa exhibits low
hygroscopicity over a wide range of RH conditions
and the TPa!TPh conversion occurs in a narrow
range of RH values. The critical RH value for the
TPa!TPh conversion obtained from this study
(RH> 79%) is similar to that obtained by Otsuka
et al.44 in a systematic temporal study of the
pseudomorphic transformation of TPa powder
exposed to different RH conditions up to 10 days,
by means of sample weighing.
Dehydration Process of TPh
Figure 7 presents the isothermal moisture desorp-
tion curves obtained for TPh from gravimetric
Table 2. Values of Rate Constant of Hydration (k), Standard Deviation of the Slope (sb), Correlation Coefficient (R
2)
and Times of Half-Hydration (t1/2) and Complete Hydration (th), Obtained for the Best Linear Fits (f(a)) Obtained for
the Three Spectral Regions Considered and for the Moisture Measurements
Spectral Region (cm1) Model f()
k
(min1) sb R
2 t1/2
a (min) th
b (min)
3060–3160 M9 0.11034þ 0.00322t 0.00322 0.00012 0.9847 292 1087
M10 0.07016þ 0.00258t 0.00258 0.00009 0.9851 314 849
900–940 M9 0.02822þ 0.00294t 0.00294 0.00016 0.9697 292 1163
M10 0.15604þ 0.00233t 0.00233 0.00014 0.9624 311 903
650–685 M9 0.04071þ 0.00291t 0.00291 0.00014 0.9754 299 1179
Moisture uptake M9 0.08399þ 0.00329t 0.00329 0.00010 0.9856 278 1056
M10 0.20171þ 0.00231t 0.00231 0.00008 0.9815 294 891
From Reference49c &580 &890
From Reference45d &1320 &2700
&840 &1980
From Reference44e &1047 &2880
aTime for half-hydration (f(a) is equal to 0.83 and 0.88 for M9 and M10, respectively, using a¼0.5).
bTime for total hydration (f(a) equal to 3.39 and 2.26 for M9 and M10, respectively, using a¼0.99999).
cInferred from Figure 1 of Reference49; dynamic vapor sorption using 95% RH after dehydration of TPh at 258C.
dInferred from Figure 3 of Reference45; gravimetry and microcalorimetry after dehydration of TPh at 1108C.
eInferred from Figure 5 of Reference44; moisture uptake using 95% RH after dehydration of TPh at 958C.
The results obtained for the linear fitting of the xTPh values as a function of time-of-exposure to water atmosphere, obtained by
sample weighting, are included in the last line. Experimental values of t1/2 and th inferred from the literature are included.
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measurements at four different temperatures: 35,
40, 47, and 608C.
At 608C, the dehydration of TPh is complete
after about 30 min, in agreement with the results
reported in previous studies.36,51 As expected, the
time required to complete dehydration increases
as temperature decreases, being of the order of ca.
120, 200, and 400 min at 47, 40, and 358C,
respectively.
All the curves present a ‘‘double-sigmoid’’
profile, with a region of slower mass decrease
(plateau) at ca. 17% water loss. This region
becomes quite evident for the 358C results, but
can be also detected in the plots of the remaining
temperature studies. The existence of regions with
different dehydration-rates is a strong evidence of
a multi-step dehydration process. Although the
studies of Shefter et al.53 and Agbada and York51
seem to indicate that dehydration of TPh occur in a
one-step process, several other studies suggest that
the process may present two steps, depending on
Figure 6. Partial Raman spectra, in the region of 3060–3160 cm1, obtained for
samples of TPa (commercial powder) stored at different RH values for 1 week at 228C (left
side) and plot of the measured ah ratio as a function of the RH-values. Equivalent plots for
the 650–685 cm1 and 900–940 cm1 spectral regions are presented in Figure 6S of the
Supplementary Material.
Figure 7. Isothermal moisture desorption curves
obtained for TPh from gravimetric measurements at
four different temperatures: 35, 40, 47, and 608C as a
function of time.
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the experimental conditions (namely, dehydration
temperature).36,37,52,54,55
In fact, the definition of the experimental
conditions is critical in these studies. For instance,
Duddu et al.52 concluded that TPh dehydration is a
single-step process at 478C the, while at 408C it
involves two distinct steps. However, they used a
period of sample equilibration of 25 min, which—
according to our results—includes the first step for
the 478C conditions.
Evidences of the two-step process in TPh
dehydration are also observed in the Raman
spectra, as the observed spectral changes
follow the two periods of the isothermal moisture
desorption curves shown in Figure 7. In fact, for
each temperature studied, the first evidences of
the presence of the TPa form only appear after a
time period corresponding to the end of the plateau
observed in the corresponding isothermal moist-
ure desorption curve. This means that the
TPh!TPa transformation is delayed relative to
the starting of the dehydration process by ca, 120,
80, 20, and 15 min of storage at 35, 40, 47, and
608C, respectively.
During this time interval, no changes are
observed in the Raman spectra of the samples,
despite the loss of ca. 17% of their water content.
The only exception occurs in the 1215–1270 cm1
region, where a slight intensity increase of a band
centered at ca. 1231 cm1 is observed during the
first time period (until end of theplateau), while its
disappearance is be expected on passing from TPh
to TPa (in fact, it is absent in the spectrum of TPa).
Based on this information, the band was assigned
to the metastable form TPm.65
On the whole, the two experiments (weighting
and FT-Raman measurements) are consistent
with a two-step mechanism for the pseudomorphic
TPh!TPa transformation
In the first step, the sample starts to lose water
until approximately 17% of the total water has
been lost. This gives rise to a metastable form,
which corresponds to a polymorphic species of
transition (TPm) that retains the TPh   TPh
intermolecular interactions of the hydrate.
The metastable form retains the hydrate main
structural characteristics, which explains why
there are nearly no Raman spectral evidences of
the TPh!TPm transformation during this step
(the vibrational modes in both TPh and TPm forms
occur at very similar wavenumbers). The second
step starts when the low water content triggers the
collapse of the TPm form to the TPa structure.
After this point, which is dependent on the storage
temperature, the dehydration evolves further at
constant rate, as indicated by the mass decrease in
the gravimetric studies and by the increase of the
Raman bands assigned to the TPa form.
The formation of a metastable form during the
dehydration of TPh at defined temperatures has
been widely referred in the literature.35–37 Accord-
ing to Phadnis et al.35 and Karjalainen et al.,37 this
form only appears if the dehydration is performed
at temperatures above 408C. However, the herein
presented results clearly indicate that this species
can form at all storage temperatures. Even at
temperature of 228C, with appropriate RH condi-
tions to induce the dehydration, the FT-Raman
spectra evidence the formation of the metastable
form. Its conversion to the TPa polymorph (the
room-temperature stable species) is as faster as
higher the storage temperature, thus turning its
detection more or less feasible.
The involvement of this metastable form in the
conversion pathway precludes the evaluation of
the kinetics of the dehydration process. This is
probably the reason why the reported kinetic
results of the literature (values of rate constants
and choice of the kinetic model) are so different
from each other.44,45,49 However, it is possible to
evaluate the kinetic parameters for the second
step, using the points shown in Figure 7 after
the plateau. The results for this second step can
be identically described by either the Avrami–
Erofeev models or by the simple a zero-order
diffusion mechanism (r2 values and sb values
within 0.98–0.99 and 0.00030–0.00060 intervals,
respectively).
Critical RH for TPh
To best of our knowledge, the critical RH condi-
tion for the TPh!TPa conversion have not been
evaluated. Zhu et al.70 report a value of 0.25 for
the critical water activity for TP solutions in
organic solventþwater mixtures. However, this
value gives no clues concerning the behavior of
samples exposed to atmosphere RH conditions,
since it refers to direct contact with the solvent in
TPhðsolidÞ ! TPmðsolidÞ þ H2OðgasÞ dehydration step
TPm ðsolidÞ ! TPaðsolidÞ structural conversion step
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saturated solutions. According to our results,
the full dehydration after 1-week exposure is
observed for RH¼ 20%. However, after exposure
to RH¼ 30% (at 258C), the spectrum of TPh
already shows the presence of small amounts of
TPa. In this way, the critical RH for TP dehydra-
tion lies closely above 30%.
CONCLUSIONS
Raman spectroscopy was found to be a suitable
technique for the quantification of anhydrate and
hydrate forms in molecular powder systems, since
the vibrational spectra is highly sensitive to the
strong intermolecular interactions present in
these systems. In the case of theophylline, there
are several spectral regions which could be used
for a reliable quantification of the hydrate–
anhydrate phase transformations.
The hydration of TPa is a one-step random
nucleation process, described by the Avrami–
Erofeev equation of exponent 12, with a rate
constant of ca. 0.003 min1, which corresponds to
a half-life time of ca. 5 h. On the other hand,
the dehydration occurs through a two-step
mechanism, involving a metastable form.
These observations reinforce the need for con-
trolled storage conditions in order to avoid
unwanted drug transformations. The TPa!TPh
pseudo-morphic transformation is a temperature-
controlled process at constant 100% RH condi-
tions, and does not require direct contact between
drug and bulk water. Both pseudopolymorphic of
teophylline forms are stable within the 30–79%
RH interval, but the conversion will occur within a
day-scale for storage outside this RH interval.
EXPERIMENTAL SECTION
TP Samples
Anhydrous TP (TPa) was obtained commercially
(Sigma-Aldrich, St. Louis, MO) and used without
further purification (grain size between 250 and
125 mm).
TP monohydrate (TPh) was prepared by dissol-
ving TPa in distilled water at 608C until a super-
saturated solution is prepared. When the solution
was allowed to slowly cool to room temperature,
needle-like crystals of the monohydrate were
formed. These were filtered from the mother
liquid, allowed to dry at ambient temperature
and RH conditions, and then gently milled to fine
powder (grain size between 250 and 125 mm).
Sample Treatment
In a first type of experiments, TPa samples of
ca. 0.1 g were transferred to small reservoirs and
exposed to the water atmosphere (RH¼ 100%),
without direct contact between the sample and
the bulk liquid (see Fig. 8). After defined time
intervals of exposure, small amounts were quickly
sealed in glass capillary tubes and the FT-Raman
spectra recorded.
In a second type of experiments, TPh samples
(ca. 0.1 g) were submitted to different tempera-
tures (35, 40, 47, and 608C) during defined time
periods, and sealed in glass capillary tubes in order
to record their FT-Raman spectra.
Finally, the TPa and TPh samples (ca. 0.1 g)
were exposed to defined RH conditions, using the
same experimental apparatus (Fig. 8), created by
using saturated salt solutions with deposit.
The RH-values considered (and salt used) were
taken from71 and are: 9% (KOH), 13% (LiCl),
20% (KC2H3O2), 30% (CaCl2) 42% (Zn(NO3)2,
48% (KCNS), 52% NaHSO4), 58% (NaBr), 61%
(NH4NO3), 66% (NaNO2), 78% (Na2SO3),
79% (NH4Cl), 81% ((NH4)2SO4), 84% (KBr), 86%
(KHSO4), and 92% (KNO3). The RHs of 0% and
100% were achieved by considering anhydrous
CuSO4 or silica and pure water, respectively. In all
cases, the exposure time was of 1 week in order to
guarantee the equilibrium moisture condition.
All experiments were performed at 228C ambi-
ent temperature and repeated three times. The
moisture content was evaluated in all cases by
performing a parallel set of experiments, and
weighing the samples before and after exposure
to the desired experimental condition.
FT-Raman Spectra
The FT-Raman spectra were recorded on a RFS-
100 Bruker FT-spectrometer, using a Nd:YAG
laser with excitation wavelength of 1064 nm, with
Figure 8. Schematic representation of the reservoir
used for sample exposure to specific RH-values (see text)
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laser power set to 300 mW. Each spectrum is the
averaging of two repeated measurements of 100
scans each and 2 cm1 resolution.
It has been reported that in some experiments
the sample temperature can rise significantly due
to laser exposure.72,73 This heating effect can, for
instance, lead either to polymorphic transforma-
tions or loss of solvent molecules. In order to
evaluate this effect on the present results, a
sample of theophylline monohydrate was exposed
continuously to 300 mW laser power for 2 h.
During this time, several records of 2 min each
were recorded. The comparison of the spectra
allowed to conclude that during the time needed
for the record of each spectrum (record of two
measurements of 100 scans each takes about
20 min) no spectral alteration was notable. In fact,
a first spectral change assignable to sample
heating (denoting some loss of water molecules),
although still extremely subtle, became observable
after 40 min of exposure to the laser (undisputable
spectral changes are only observable after about
50 min of exposure).
Spectral Band Deconvolution and
Mathematical Data Treatment
Band areas were determined by fitting to the
spectral regions used Lourentzian or Gaussian
functions, after performing a linear baseline
correction employing three points. The dTPh/dTPa
ratio, required to obtain the values of the
fractional of transformation, aTPa and aTPh from
the measured band intensities (see Eqs. 2 and 3),
were determined by fitting procedures, using
physical mixtures of both components with
defined composition (TPh molar fractions of 0.00,
0.08, 0.19, 0.33, 0.44, 0.49, 0.51, 0.64, 0.84, 0.89,
1.00 were used).
Different standard statistical criteria may be
used to determine the aggregate deviation of a set
of measured points from the calculated linear
relationship. The most usually used are the
correlation coefficient (R2) and the standard error
of the slope of the regression line (sb). Some
authors67,74 have reported the inadequacies of
using r-value as the sole determinant of the
applicability of a particular kinetic model, parti-
cularly for distinguishing between mechanism
that yield similar linear correlation coefficients
(R2). Davis and Pryor74 pointed out the advantages
of using sb-values instead. In this work, the quality
of the linear fit obtained for each kinetic model
tested (Tab. 1) is determined by considering both
R2- and sb-values.
Table 3 presents the results obtained for the
linear fitting of the predicted relative concentra-
tion as a function of the known molar fraction of
TPh-TPa physical mixtures. As stated in the
Results and Discussion Section, only three spec-
tral regions, namely 3060–3160 cm1, 900–
940 cm1, and 650–685 cm1, were considered
in the scope of the present work. For the 900–
940 cm1 and 650–685 cm1 spectral regions, the
Raman spectrum of pure TPa shows the presence
of a small intensity band in the region ascribed to
the TPh bands (bands marked with a asterisk (*) in
Fig. 4). The presence of these bands could result
from a small contamination of the TPa sample with
either TPh or a metastable TPm form known to be
formed during dehydration at low temperatures
(Results and Discussion). However, the compar-
ison of the relative intensities of these bands is not
consistent with the presence of any amount of TPh,
Table 3. Results Obtained for the Linear Fitting of the Predicted Relative Concentration as a Function of the
Known Molar Fraction of TPh/TPa Physical Mixtures
Spectral Region
Band Center (cm1)
Vibrational
Modea TPa TPh bb sb
b ab R2 b TPa=TPh
b
3060–3160 cm1 C8H 3123 3109 1.0075 0.04 0.0002 0.99 0.5
1300–1340 cm1c nCCþ nCN 1315 1322 0.8286 0.03 0.0077 0.99 0.3
900–940 cm1 aimidazole 928 918 0.9829 0.03 0.0137 0.99 0.3
650–685 cm1 apyrimidine 668 674 0.9504 0.03 0.0109 0.99 0.5
510–600 cm1c apyrimidine 555 572 0.9067 0.03 0.0051 0.99 0.6
aIn accordance with Reference65; n and a stand for stretching and deformation, respectively.
bb, sb, and a stand for slope, slope standard deviation and y-intercept of the linear regression line, respectively;R
2 for the correlation
coefficient; dTPh and dTPa stand for intrinsic intensities of the mode for the TPh and TPa forms, respectively.
cIn this spectral regions a third band had to be considered in the deconvolutionprocedure to account for the asymmetry of the overall
band profile (band centers at 1310 cm1 and at 581 cm1).
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and hence they are ascribed to the TPm form. It
should be mentioned that the linear fits presented
in Table 3 improve when the intensity of these
bands is subtracted from the total TPh intensity.
Table 3 also presents the fitting results for two
other spectral regions (510–600 cm1 and 1300–
1340 cm1) as they can be used if necessary
(namely in studies involving mixtures with exci-
pients, for instance) with some caution. In fact, the
deconvolution of these spectral regions were found
to require more than two band centers (Tab. 3).
The remaining spectral regions marked in
Figure 3 either do not present a single isosbestic
point or include Raman bands ascribed to Fermi
resonance modes,65 and thus preclude a kinetic
analysis.
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